UnitedHealth Note 8: Risk Point Tracking

UnitedHealth (UNH) Core Risk Tracking List

(April 2026 Edition · For tracking reference only, not investment advice)

I. DOJ Criminal + Antitrust Investigation (Largest Tail Risk)

Basis

• U.S. Department of Justice conducting criminal investigation into UNH: Suspected Medicare billing fraud, false claims (False Claims Act)

• Concurrent antitrust investigation: Questioning monopoly formed by vertical integration of Optum (medical services) + UnitedHealthcare (insurance), related-party transactions raising costs

• Key milestones of related judicial proceedings brought forward to October 2026, entering intensive evidence collection/hearing phase

Impact on Fundamentals

• Potential fine scale: $5-20 billion range, directly erasing years of net profit

• Worst-case scenario: Forced spin-off of insurance and Optum businesses, complete business model restructuring

• Soaring compliance costs, business expansion paused, management attention severely occupied

Impact on Stock Price

• Sustained valuation discount before resolution: -20% to -30%

• News of indictment/forced spin-off: Could drop -15% to -25% in a single day

• If convicted/forced spin-off: Stock price likely to fall below $250, extreme case $220 to $240

Tracking Signals

• Court hearing announcements, regulatory filing disclosures, media reports of escalated investigation

• Company discloses significant increase in legal reserves

• Official announcements of "asset divestiture/business rectification" emerge

II. Profitability & Medical Cost Risk (Core Fundamental Pressure)

Basis

• 2025 Q4 GAAP net profit only $10 million, down 95% YoY

• 2026 revenue guidance down 2% YoY, first negative growth in over 30 years

• Medical Cost Ratio (MCR) rises to 89.1%, nearing breakeven point

• Medical cost growth ~11%, far exceeding premium increase rates

• Company proactively cuts 2.2-2.8 million members, divests low-margin businesses

Impact on Fundamentals

• Growth engine stalls, shifting from "high-certainty growth" to profit recovery struggle period

• If MCR persistently >90%, insurance business will incur widespread losses

• Cutting members to preserve profit damages long-term growth logic

Impact on Stock Price

• Valuation center shifts downward: from historical 20-22x PE to 15-17x

• Earnings report misses expectations: Single-day -10% to -20% plunge (verified in January)

• Two consecutive quarters of MCR exceeding expectations: High probability of testing $250

Tracking Signals

• Quarterly report MCR, net profit, member count changes

• Whether 2026 performance guidance is lowered again

• Whether Optum business margins weaken simultaneously

III. CMS Long-term Regulatory Tightening (Growth Logic Suppression)

Basis

• 2027 Medicare Advantage final rate increase 2.48%, far below historical 4%-6%

• CMS strengthens RADV audits, industry-wide recovery of over $5 billion in overpayments

• Risk adjustment coding rules tightened: Prohibiting raising reimbursement amounts with unrelated diagnoses

• Continues to advance pricing transparency, cost control, reducing insurer profit margins

Impact on Fundamentals

• Core profit source MA business enters low/no growth era

• Historical "coding dividend" permanently disappears, industry profit margins shift downward

• Premium increase space locked, cost pressure cannot be passed on

Impact on Stock Price

• Growth attribute disappears, shifts from growth stock to low-growth utility-like

• Valuation difficult to return to historical highs, 15x PE may become the norm

• Each regulatory detail announcement brings phased declines of -5% to -10%

Tracking Signals

• CMS new policy announcements, audit fine amounts

• MA member growth rate, profit per member changes

IV. Political & Election Policy Risk (Source of High Volatility)

Basis

• 2026 election year, both parties using controlling healthcare costs, suppressing insurer profits as campaign leverage

• Donald Trump policy direction: Cutting MA payments, strengthening price controls, intensifying regulation

• Healthcare giants have become political targets, sustained headwinds from public opinion and policy

Impact on Fundamentals

• Policy environment remains unfavorable for next 2-3 years

• Pricing, expansion, M&A all potentially subject to administrative intervention

• Industry enters strong regulatory cycle, business model ceiling lowered

Impact on Stock Price

• Annual volatility significantly amplified

• Policy negative rumors alone can "kill valuation," single-day -8% to -12%

• Safe-haven attribute completely disappears, continuous capital outflow

Tracking Signals

• Election debates, healthcare-related bill proposals

• White House/regulatory agency speeches targeting healthcare industry
V. Cybersecurity & Operational Risk (Sudden Black Swan)

Basis

• Suffered major cyber attack in 2025, direct losses approximately $1.6 billion

• System extremely large and complex, massive customer data, non-negligible probability of another attack

• Recent executive changes, business restructuring, rising internal execution risk

Impact on Fundamentals

• One-time huge loss + long-term rising IT/compliance costs

• Service disruptions lead to member attrition, brand trust damage

Impact on Stock Price

• Sudden security incident: Single-day -5% to -15%

• Lengthens recovery period, further suppresses valuation

Tracking Signals

• Company discloses security incidents, system outage announcements

• Abnormal large increases in IT and legal expenditures

II. Stock Price Scenario Range Summary

1) Baseline Scenario (Risks do not worsen)

• CMS stable, DOJ no major escalation, MCR controllable

• Stock price range: $290-$330

2) Negative News Realization Scenario (Any one occurs)

• DOJ indictment / MCR persistently >90% / earnings guidance lowered again

• Stock price range: $250-$280

3) Extreme Risk Scenario

• Forced spin-off / huge fine + profit double whammy

• Stock price range: $220-$240

$Unitedhealth(UNH.US)